Immunology and Microbiology
Taenia Solium
78%
Cysticercosis
69%
Prevalence
47%
Neurocysticercosis
42%
Pig
31%
Chagas Disease
29%
Mycobacterium Tuberculosis
29%
Helicobacter Pylori
28%
Monospecific Antibody
23%
Human Immunodeficiency Virus
21%
Trypanosoma Cruzi
20%
Pylorus
19%
Enzyme-Linked Immunosorbent Assay
18%
Infectious Agent
16%
Cestoda
15%
Oncosphere
15%
Polymerase Chain Reaction
14%
Norovirus
13%
Drug Sensitivity
13%
Cryptosporidium
12%
Seroprevalence
11%
Western Blot
11%
Antibody Response
9%
Polymerase Chain Reaction
9%
T Cell
9%
Secretion (Process)
9%
ELISA
9%
Sputum
8%
Vaccine Efficacy
8%
Serology
8%
Real-Time Polymerase Chain Reaction
8%
Plasmodium vivax
8%
Asthma
7%
Cysticercus (Cestode Larva)
7%
Monocyte
7%
Cross-Reactivity
7%
Computer Assisted Tomography
7%
Glycoprotein
7%
Cyclospora cayetanensis
7%
Altitude
6%
Echinococcosis
6%
Multi-Drug-Resistant Tuberculosis
6%
Taenia
6%
Brucella Melitensis
6%
Coinfection
6%
Praziquantel
6%
Genotype
6%
Rural Population
5%
Allele
5%
Parasitemia
5%
Keyphrases
Peru
100%
Taenia Solium
46%
Neurocysticercosis
42%
Peruvian
37%
Lima
31%
Tuberculosis
27%
Confidence Interval
27%
Cysticercosis
26%
Mycobacterium Tuberculosis (M. tb)
24%
Trypanosoma Cruzi (T. cruzi)
20%
Chagas Disease
19%
Cyst
18%
Diarrhea
17%
Helicobacter Pylori (H. pylori)
12%
Oncosphere
12%
Porcine Cysticercosis
11%
Taenia Solium Cysticercosis
11%
Developing Countries
11%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
High Altitude
10%
Genotype
9%
Multidrug-resistant Tuberculosis (MDR-TB)
9%
Bolivia
9%
Oxfendazole
9%
Taeniasis
9%
Shantytown
9%
Odds Ratio
9%
Enzyme-linked Immunoelectrotransfer Blot
9%
Hypertension
8%
Risk Factors
8%
Peri-urban
8%
Tuberculosis Diagnosis
8%
Pyrazinamide Resistance
8%
Low-middle Income Countries
8%
Chagas Cardiomyopathy
7%
Norovirus
7%
AIDS/HIV
7%
Rural-urban
7%
Cysticercus
7%
Antiparasitic Treatment
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Microscopic Observation Drug Susceptibility
7%
Diabetes
7%
Body Mass Index
7%
Urbanization
7%
Epidemiology
7%
Peruvian Amazon
6%
Polymerase Chain Reaction
6%
Drug Susceptibility Testing
6%
T. Cruzi Infection
6%
Medicine and Dentistry
Disease
45%
Infection
40%
Prevalence
32%
Chagas Disease
30%
Mycobacterium Tuberculosis
29%
Diagnosis
28%
Neurocysticercosis
28%
Drug Sensitivity
25%
Diarrhea
25%
Human Immunodeficiency Virus
20%
Lung Tuberculosis
18%
Sputum
18%
Household
16%
Multidrug Resistant Tuberculosis
16%
Health Care Cost
15%
Taenia Solium
14%
Cohort Analysis
14%
Pyrazinamide
12%
Cysticercosis
12%
Low and Middle Income Countries
12%
Symptom
12%
Childbirth
11%
Trypanosoma Cruzi
10%
Cross Sectional Study
10%
Diabetes
9%
Public Health
8%
Cohort Effect
8%
Blood Pressure
8%
Helicobacter Pylori
8%
Pediatrics
7%
Odds Ratio
7%
Polymerase Chain Reaction
7%
Tuberculosis Diagnosis
7%
Mantoux Test
7%
Polymerase Chain Reaction
7%
Pathogen
6%
Real-Time Polymerase Chain Reaction
6%
Enzyme Linked Immunosorbent Assay
6%
Maturity Onset Diabetes of the Young
6%
Pyrazinoic Acid
6%
Tuberculosis
6%
Body Mass Index
6%
Oncosphere
6%
Placebo
6%
Helicobacter Infection
6%
Chagas Cardiomyopathy
6%
Taeniasis
6%
Pylorus
5%
Case-Control Study
5%
Epileptic Seizure
5%